These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28681394)
1. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study. Kawashima M; Nemoto O; Honda M; Watanabe D; Nakayama J; Imafuku S; Kato T; Katsuramaki T; J Dermatol; 2017 Nov; 44(11):1219-1227. PubMed ID: 28681394 [TBL] [Abstract][Full Text] [Related]
2. Valaciclovir: a review of its use in the management of herpes zoster. Ormrod D; Goa K Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacological profiles and clinical effects of amenamevir tablet as treatments for herpes zoster]. Maeda H; Nakamura H; Kikukawa Y Nihon Yakurigaku Zasshi; 2019; 153(1):35-43. PubMed ID: 30643090 [TBL] [Abstract][Full Text] [Related]
4. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Perry CM; Faulds D Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster. Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360 [TBL] [Abstract][Full Text] [Related]
6. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial. Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA; J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350 [TBL] [Abstract][Full Text] [Related]
7. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Beutner KR; Friedman DJ; Forszpaniak C; Andersen PL; Wood MJ Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102 [TBL] [Abstract][Full Text] [Related]
8. Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster. Shiraki K Drugs Today (Barc); 2017 Nov; 53(11):573-584. PubMed ID: 29451274 [TBL] [Abstract][Full Text] [Related]
9. Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster. Shiraki K; Yasumoto S; Toyama N; Fukuda H Viruses; 2021 Aug; 13(8):. PubMed ID: 34452412 [TBL] [Abstract][Full Text] [Related]
10. Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA). Decroix J; Partsch H; Gonzalez R; Mobacken H; Goh CL; Walsh L; Shukla S; Naisbett B J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):23-33. PubMed ID: 10877249 [TBL] [Abstract][Full Text] [Related]
11. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Ormrod D; Scott LJ; Perry CM Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039 [TBL] [Abstract][Full Text] [Related]
12. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. McDonald EM; de Kock J; Ram FS Antivir Ther; 2012; 17(2):255-64. PubMed ID: 22300753 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Colin J; Prisant O; Cochener B; Lescale O; Rolland B; Hoang-Xuan T Ophthalmology; 2000 Aug; 107(8):1507-11. PubMed ID: 10919899 [TBL] [Abstract][Full Text] [Related]
14. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852 [TBL] [Abstract][Full Text] [Related]
15. Antiviral Drugs Against Alphaherpesvirus. Shiraki K Adv Exp Med Biol; 2018; 1045():103-122. PubMed ID: 29896665 [TBL] [Abstract][Full Text] [Related]
16. An exploratory study of the efficacy and safety of amenamevir for the treatment of herpes zoster in patients receiving immunosuppressive drugs. Imafuku S; Takeuchi S; Urabe K; Arakawa M; Sasaki R; Oka D; Yamamoto T; Ono F; Shirahama S; Yasumoto S; Fukuda H J Dermatol; 2024 Oct; 51(10):1279-1289. PubMed ID: 39046277 [TBL] [Abstract][Full Text] [Related]
17. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group. Bodsworth NJ; Crooks RJ; Borelli S; Vejlsgaard G; Paavonen J; Worm AM; Uexkull N; Esmann J; Strand A; Ingamells AJ; Gibb A Genitourin Med; 1997 Apr; 73(2):110-6. PubMed ID: 9215092 [TBL] [Abstract][Full Text] [Related]
18. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Tyring SK; Beutner KR; Tucker BA; Anderson WC; Crooks RJ Arch Fam Med; 2000; 9(9):863-9. PubMed ID: 11031393 [TBL] [Abstract][Full Text] [Related]
19. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials. Conant MA; Schacker TW; Murphy RL; Gold J; Crutchfield LT; Crooks RJ; Int J STD AIDS; 2002 Jan; 13(1):12-21. PubMed ID: 11802924 [TBL] [Abstract][Full Text] [Related]
20. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Fife KH; Barbarash RA; Rudolph T; Degregorio B; Roth R Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]